BCP increases survival and induces neuritogenesis in NGF-deprived PC12 cells. BCP activates the NGF-high affinity receptors, trkA. BCP does not increase the expression of NGF. BCP increases the expression of axonal-plasticity-associated proteins. The neuritogenic effect of BCP is independent of cannabinoid receptors.